Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eyecare OMK1
- Development stage
- Unknown
- Lead developer
- Omikron
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Eyecare OMK1 is a sterile ophthalmic topical solution developed and marketed by DÁVI, a Portuguese pharmaceutical company. The formulation is a combination of 2% citicoline and 0.2% high molecular weight hyaluronic acid. It is primarily indicated as an adjuvant treatment for patients with glaucoma, where citicoline provides neuroprotective structural support to retinal ganglion cells and helps restore the integrity of cell membranes damaged by degenerative eye diseases. The hyaluronic acid component acts as a lubricant and stabilizer for the tear film, providing moisturizing and protective properties for the ocular surface. This solution also offers relief for eye irritation, burning, and foreign body sensations caused by environmental factors, eye surgery, or conjunctivitis. Regulated as a medical device, it is administered topically to the eye.
- Brand names
- Eyecare OMK1
- Other names
- OMK1OMK-1OMK 1
Beyond the preview
Go deeper on Eyecare OMK1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eyecare OMK1.